Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study

Christopher R. Flowers, Chadi Nabhan, Neil Elliot Kay, Anthony Mato, Nicole Lamanna, Charles M. Farber, Matthew S. Davids, Pavel Kiselev, Arlene S. Swern, Kristen Sullivan, E. Dawn Flick, Jeff P. Sharman

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect<sup>®</sup> CLL cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences